Latest
 
  • All Share : 53344.2008
    UP 0.02%
    Top40 - (Tradeable) : 47161.8336
    UNCHANGED0.00%
    Financial 15 : 16911.0896
    DOWN -0.73%
    Industrial 25 : 66349.6236
    UNCHANGED0.00%
    Resource 10 : 45729.948
    UP 0.69%

  • ZAR/USD : 11.6585
    DOWN -0.02%
    ZAR/GBP : 17.9655
    UP 0.03%
    ZAR/EUR : 13.0505
    UP 0.02%
    ZAR/JPY : 0.097
    UP 0.94%
    ZAR/AUD : 9.1075
    UNCHANGED0.00%

  • Gold US$/oz : 1213.03
    UNCHANGED0.00%
    Platinum US$/oz : 1188.13
    UNCHANGED0.00%
    Silver US$/oz : 16.6
    UNCHANGED0.00%
    Palladium US$/oz : 817.6
    UNCHANGED0.00%
    Brent Crude : 62
    UNCHANGED0.00%

  • All data is delayed by 15 min. Data supplied by Profile Data
    Hover cursor over this ticker to pause.

Sat Feb 28 22:49:12 SAST 2015

US soldier receives rare double arm transplant

Sapa-AFP | 29 January, 2013 12:42

A US soldier who lost all four limbs in a 2009 roadside bomb attack in Iraq has successfully received a rare double arm transplant, Johns Hopkins hospital said.

The infantryman, whose name and age were not released, is one of just seven people in the United States who have successfully received the complex transplant.

The first successful double arm transplant was in 2008 in Germany.

This latest transplant was paired with an innovative treatment to prevent rejection of the new limbs which involved an infusion of the deceased donor's bone marrow cells.

It "has so far succeeded in both preventing rejection and reducing the need for anti-rejection drugs, which can cause complications such as infection and organ damage," Johns Hopkins said in a statement.

The transplant involved the connection of bones, blood vessels, muscles, tendons, nerves and skin on both arms.

More details will be presented Tuesday at a press conference with the surgeons and soldier, who also agreed to participate in a study of the new anti-rejection regimen sponsored by the Armed Forces Institute of Regenerative Medicine.

SHARE YOUR OPINION

If you have an opinion you would like to share on this article, please send us an e-mail to the Times LIVE iLIVE team. In the mean time, click here to view the Times LIVE iLIVE section.